Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

75.76
Delayed Data
As of Aug 23
 -1.64 / -2.12%
Today’s Change
71.53
Today|||52-Week Range
106.74
-11.03%
Year-to-Date
No recent news for Biomarin Pharmaceutical Inc.

Today’s Trading

Previous close77.40
Today’s open77.28
Day’s range75.49 - 77.47
Volume1,218,181
Average volume (3 months)1,331,913
Market cap$13.6B
Data as of 4:00pm ET, 08/23/2019

Growth & Valuation

Earnings growth (last year)+34.91%
Earnings growth (this year)-8.61%
Earnings growth (next 5 years)+52.80%
Revenue growth (last year)+13.51%
P/E ratioNM
Price/Sales10.07
Price/Book4.55

Competitors

 Today’s
change
Today’s
% change
EXASExact Sciences Corp-0.91-0.77%
NBIXNeurocrine Bioscienc...+0.35+0.36%
TECHBio-Techne Corp-3.81-1.99%
BLUEbluebird bio Inc-2.98-2.72%
Data as of 4:00pm ET, 08/23/2019

Financials

Next reporting dateOctober 28, 2019
EPS forecast (this quarter)$0.06
Annual revenue (last year)$1.5B
Annual profit (last year)-$77.2M
Net profit margin-5.16%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Dan Spiegelman
Corporate headquarters
San Rafael, California

Forecasts